Nimodipine and Perfusion Changes After Stroke "NIMPAS"


Phase N/A Results


In the nimodipine group, there was early reperfusion that did not persist at 3 months (P=0.01). In the placebo group, mean infarct hypoperfusion volumes showed no overall change. Nonnutritional reperfusion in nimodipine-treated patients was associated with adverse neurological (P=0.05) and functional outcome (P=0.06).